← Back
$TEVA All transactions

TEVA PHARMACEUTICAL INDUSTRIES LTD

A

$ Value

$0

Shares

141,478

Price

$0

Filed

Jan 29

Insider

Name

Kalif Eliyahu Sharon

Title

EVP, Chief Financial Officer

CIK

0001798443

Roles

Officer

Transaction Details

Transaction Date

2026-01-27

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

141,478

Footnotes

Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. | Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 3, 2026. | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Filing Info

Accession No.

0001193125-26-029337

Form Type

4

Issuer CIK

0000818686

Kalif Eliyahu Sharon's History

Date Ticker Type Value
2026-03-05 TEVA M
2026-03-05 TEVA M $0
2026-03-04 TEVA M
2026-03-04 TEVA M
2026-03-04 TEVA M $0
2026-03-04 TEVA M $0
2026-03-04 TEVA A $0
2026-03-03 TEVA M
2026-03-03 TEVA M
2026-03-03 TEVA M $0

Other Insiders at TEVA (90d)

Insider Bought Sold Last
Francis Richard D
President and CEO
$31.1M 2026-03-05
Sabag Mark
See "Remarks"
2026-03-05
Daniell Richard
EVP, Europe Commercial
$7.7M 2026-03-05
Daniell Richard
Exec. VP, European Commercial
2026-01-27
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
$11.6M 2026-03-05
Weiss Amir
Chief Accounting Officer
2026-03-05
Hughes Eric A
See "Remarks"
$3.3M 2026-03-05
Fox Christine
EVP, U.S. Commercial
$546K 2026-03-05
Shields Matthew
EVP, Global Operations
$548K 2026-03-05
Jover Placid
See "Remarks"
$448K 2026-03-05
Lippman Evan
EVP, Business Development
2026-03-04
Savage Brian
Interim Chief Legal Officer
$164K 2026-03-05